Form 4 for LLY Lilly (Eli)
Accepted 2025-08-04 00:00:00 ET · period of report 2025-08-01 · accession 0000059478-25-000198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-04 | 2025-08-01 | LLY | Seymour Melissa | EVP, Gbl Quality | M - OptEx | $0.00 | +952 | 952 | New | $0 |
| D | 2025-08-04 | 2025-08-01 | LLY | Seymour Melissa | EVP, Gbl Quality | F - Tax | $740.07 | -426.92 | 525.08 | -45% | -$316.0K |
| D | 2025-08-04 | 2025-08-01 | LLY | Seymour Melissa | EVP, Gbl Quality | M - OptEx | $0.00 | -952 | 1,933 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-01 | M | A | 952 | $0.00 | 952 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-01 | F | D | 426.92 | $740.07 | 525.08 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-08-01 | M | D | 952 | $0.00 | 1,933 | D | — · — to — | 952 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. (F2) The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027. |